LFSC

$36.31

Fund Essentials - as of Sep 30, 2025

Net Assets
$93M
Expense Ratio
0.54%
Dividend Yield (Current)
-
Holdings
36
Inception Date
Oct 30, 2024
Fund Family
Emerald ETF
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
NA
SEC 30-Day Yield
••••••••••

Performance

YTD-0.02%
1 Year+0.38%
3 Year+0.43%
5 Year+0.43%
10 Year+0.43%

Asset Allocation

Stocks: 99.05%
Other: 0.97%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
TVTXTravere Therapeutics Inc7.17%
LIVNLivanova Plc5.74%
COGTCogent Biosciences Inc5.20%
SLNOSoleno Therapeutics, Inc.5.16%
TMDXTransmedics Group Inc4.81%
Top 10 Concentration: 48.37%Report Date: Sep 30, 2025

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
-1.60%
YTD
+37.87%
1 Year
+37.87%
3 Year
+43.19%

Top 10 Holdings (48.4% of portfolio)

#TickerNameSectorWeight
1TVTXTravere Therapeutics IncHealth Care7.17%
2LIVNLivanova PlcHealth Care5.74%
3COGTCogent Biosciences IncHealth Care5.20%
4SLNOSoleno Therapeutics, Inc.Health Care5.16%
5TMDXTransmedics Group IncHealth Care4.81%
6GHGuardant Health IncHealth Care4.40%
7NKTRNektar Therapeutics Class AUnknown4.19%
8BBIOBridgebio Pharma IncHealth Care3.97%
9MDGLMadrigal Pharmaceuticals IncHealth Care3.95%
10RDNTRadnet IncHealth Care3.78%